Trade Report: Today, US Bancorp DE Sold shares of Aflac Inc. (AFL)

Today, US Bancorp DE Sold shares of Aflac Inc. (AFL)

US Bancorp DE reduced its stake in Aflac Inc. (NYSE:AFL) by 1.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 234,231 shares of the company’s stock after selling 3,099 shares during the period. US Bancorp DE owned about 0.06% of Aflac worth $16,834,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in AFL. Global X Management Co. LLC increased its position in Aflac by 2,617.5% in the second quarter. Global X Management Co. LLC now owns 1,549 shares of the company’s stock valued at $112,000 after buying an additional 1,492 shares during the period. Tower Research Capital LLC TRC increased its position in Aflac by 51.2% in the second quarter. Tower Research Capital LLC TRC now owns 1,736 shares of the company’s stock valued at $125,000 after buying an additional 588 shares during the period. Oakworth Capital Inc. increased its position in Aflac by 62.4% in the second quarter. Oakworth Capital Inc. now owns 1,835 shares of the company’s stock valued at $127,000 after buying an additional 705 shares during the period. Trust Department MB Financial Bank N A increased its position in Aflac by 291.9% in the second quarter. Trust Department MB Financial Bank N A now owns 2,171 shares of the company’s stock valued at $135,000 after buying an additional 1,617 shares during the period. Finally, Capital Analysts LLC increased its position in Aflac by 159.4% in the second quarter. Capital Analysts LLC now owns 4,033 shares of the company’s stock valued at $159,000 after buying an additional 2,478 shares during the period. 63.17% of the stock is currently owned by hedge funds and other institutional investors.

Aflac Inc. (NYSE:AFL) traded down 0.17% on Friday, reaching $71.50. 207,708 shares of the company’s stock were exchanged. The firm has a 50 day moving average of $70.73 and a 200-day moving average of $71.29. Aflac Inc. has a one year low of $54.57 and a one year high of $74.50. The stock has a market cap of $29.18 billion, a price-to-earnings ratio of 11.33 and a beta of 1.07.

Aflac (NYSE:AFL) last posted its earnings results on Thursday, October 27th. The company reported $1.82 EPS for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.08. Aflac had a net margin of 12.03% and a return on equity of 13.72%. The company had revenue of $5.72 billion for the quarter, compared to analysts’ expectations of $5.75 billion. During the same quarter in the prior year, the company posted $1.32 earnings per share. Aflac’s revenue for the quarter was up 13.4% compared to the same quarter last year. Equities research analysts forecast that Aflac Inc. will post $6.95 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 1st. Shareholders of record on Wednesday, November 16th will be given a $0.43 dividend. The ex-dividend date is Monday, November 14th. This represents a $1.72 dividend on an annualized basis and a yield of 2.40%. This is a boost from Aflac’s previous quarterly dividend of $0.41. Aflac’s dividend payout ratio is presently 27.30%.

Several equities research analysts recently weighed in on AFL shares. Vetr upgraded shares of Aflac from a “hold” rating to a “buy” rating and set a $74.76 price target on the stock in a research report on Wednesday, November 16th. Deutsche Bank AG restated a “hold” rating and issued a $73.00 price target (down previously from $75.00) on shares of Aflac in a research report on Monday, August 1st. Wells Fargo & Co. started coverage on shares of Aflac in a research report on Friday, September 23rd. They issued a “market perform” rating on the stock. FBR & Co restated a “hold” rating on shares of Aflac in a research report on Friday, October 28th. Finally, Credit Suisse Group AG started coverage on shares of Aflac in a research report on Friday, October 7th. They issued an “underperform” rating and a $75.00 price target on the stock. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $70.21.

In other news, insider Teresa L. White sold 35,734 shares of the stock in a transaction dated Thursday, September 1st. The shares were sold at an average price of $74.28, for a total transaction of $2,654,321.52. Following the sale, the insider now owns 29,633 shares of the company’s stock, valued at $2,201,139.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Audrey B. Tillman sold 1,500 shares of the stock in a transaction dated Tuesday, August 30th. The stock was sold at an average price of $73.98, for a total transaction of $110,970.00. Following the sale, the insider now directly owns 33,958 shares in the company, valued at approximately $2,512,212.84. The disclosure for this sale can be found here. 3.90% of the stock is currently owned by company insiders.

About Aflac

Aflac Incorporated is a business holding company. The Company engaged in is supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). Aflac’s insurance business consists of two segments: Aflac Japan and Aflac U.S.

Receive News & Ratings for Aflac Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aflac Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment